TAK
Takeda Pharmaceutical Company Limited
$16.4
Earnings Summary
Revenue | $972465Mn |
Net Profits | $105014Mn |
Net Profit Margins | 10.8% |
Highlights
Takeda Pharmaceutical Company Limited’s revenue jumped 2.41% since last year same period to $972465Mn in the Q2 2022. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 11.36% jump in its revenue since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit fell -23.73% since last year same period to $105014Mn in the Q2 2022. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 1024.58% jump in its net profits since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit margin fell -25.52% since last year same period to 10.8% in the Q2 2022. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 930.29% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Takeda Pharmaceutical Company Limited post its latest quarter earnings
EPS Estimate Current Quarter | 0.15 |
EPS Estimate Current Year | 0.15 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.15 - a -54.49% fall from last quarter’s estimates.
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.15.
Key Ratios
Key ratios of the Takeda Pharmaceutical Company Limited post its Q1 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2023. This indicates that the Takeda Pharmaceutical Company Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2020-01-10 | 75 | 3 | -96% |
2019-04-25 | -0.36 | -0.62 | -72.22% |
2019-07-31 | -0.19 | -0.06 | 67.68% |
2019-10-31 | -0.21 | 0.16 | 176.19% |
Company Information
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.
Organisation | Takeda Pharmaceutical Company Limited |
Headquarters | 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 |
Employees | 47347 |
Industry | Health Technology |
CEO | Christophe Weber |
Discover More Earning Stocks in Health Technology Sector
Trading and brokerage services provided by
Banking and Remittance services provided by
Technology services provided by : Finzoomers Services Private Limited
Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*